Dror Bashan - Net Worth and Insider Trading

Dror Bashan Net Worth

The estimated net worth of Dror Bashan is at least $223,952 dollars as of 2024-11-29. Dror Bashan is the PRESIDENT AND CEO of Protalix BioTherapeutics Inc and owns about 132,516 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $223,952. Details can be seen in Dror Bashan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dror Bashan has not made any transactions after 2023-10-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dror Bashan

To

Dror Bashan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dror Bashan owns 1 companies in total, including Protalix BioTherapeutics Inc (PLX) .

Click here to see the complete history of Dror Bashan’s form 4 insider trades.

Insider Ownership Summary of Dror Bashan

Ticker Comapny Transaction Date Type of Owner
PLX Protalix BioTherapeutics Inc 2023-10-19 director & President and CEO

Dror Bashan Latest Holdings Summary

Dror Bashan currently owns a total of 1 stock. Dror Bashan owns 132,516 shares of Protalix BioTherapeutics Inc (PLX) as of October 19, 2023, with a value of $223,952.

Latest Holdings of Dror Bashan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PLX Protalix BioTherapeutics Inc 2023-10-19 132,516 1.69 223,952

Holding Weightings of Dror Bashan


Dror Bashan Form 4 Trading Tracker

According to the SEC Form 4 filings, Dror Bashan has made a total of 2 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 64,516 shares on October 19, 2023, which cost Dror Bashan around $90,322.

Insider Trading History of Dror Bashan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dror Bashan Trading Performance

GuruFocus tracks the stock performance after each of Dror Bashan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dror Bashan is -9.11%. GuruFocus also compares Dror Bashan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dror Bashan within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dror Bashan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dror Bashan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.18 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -12.53 LIMIT LIMIT LIMIT LIMIT LIMIT

Dror Bashan Ownership Network

Ownership Network List of Dror Bashan

No Data

Ownership Network Relation of Dror Bashan

Insider Network Chart

Dror Bashan Owned Company Details

What does Protalix BioTherapeutics Inc do?

Who are the key executives at Protalix BioTherapeutics Inc?

Dror Bashan is the director & President and CEO of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include 10 percent owner Dexcel Pharma Technologies Ltd. , 10 percent owner Dan Oren , and Sr. VP and CFO Eyal Rubin .

Protalix BioTherapeutics Inc (PLX) Insider Trades Summary

Over the past 18 months, Dror Bashan made 1 insider transaction in Protalix BioTherapeutics Inc (PLX) with a net purchase of 64,516.

In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.

Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Protalix BioTherapeutics Inc Insider Transactions

No Available Data

Dror Bashan Mailing Address

Above is the net worth, insider trading, and ownership report for Dror Bashan. You might contact Dror Bashan via mailing address: 2 Snunit St, Science Park, Pob 455, Carmiel L3 L3 20100.

Discussions on Dror Bashan

No discussions yet.